Reference health
Association of Dose Tapering With Overdose or Mental Health Crisis Among Patients Prescribed Long-term Opioids
28/28 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
4 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 28 checked references that resolve
resolves10.15585/mmwr.mm655051e1
Increases in Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015
resolves10.1136/bmj.k2833
Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study
resolves10.7326/M14-2559
The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop
resolves10.1001/jama.2016.1464
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
resolves10.1001/jamanetworkopen.2019.16271
Trends and Rapidity of Dose Tapering Among Patients Prescribed Long-term Opioid Therapy, 2008-2017
resolves10.7326/M18-1243
Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention's 2016 Opioid Guideline
resolves10.1016/j.jpain.2016.11.003
Prescription Opioid Taper Support for Outpatients With Chronic Pain: A Randomized Controlled Trial
resolves10.1136/bmj.m283
Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation
resolves10.1016/j.drugalcdep.2020.108248
The Association between Opioid Discontinuation and Heroin Use: A Nested Case-Control Study
resolves10.1016/j.jsat.2019.05.001
Opioid medication discontinuation and risk of adverse opioid-related health care events
resolves10.1007/s11606-019-05301-2
Mortality After Discontinuation of Primary Care–Based Chronic Opioid Therapy for Pain: a Retrospective Cohort Study
resolves10.2105/AJPH.2018.304590
Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic
resolves10.1136/injuryprev-2019-043521
Defining indicators for drug overdose emergency department visits and hospitalisations in ICD-10-CM coded discharge data
resolves10.1002/pds.v26.5
resolves10.1177/0033354920904087
ICD-10-CM–Based Definitions for Emergency Department Opioid Poisoning Surveillance: Electronic Health Record Case Confirmation Study
resolves10.1186/s12888-014-0289-5
Systematic review and assessment of validated case definitions for depression in administrative data
resolves10.1093/ije/dyz038
A systematic review of validated suicide outcome classification in observational studies
resolves10.1097/MLR.0000000000000735
Identifying Increased Risk of Readmission and In-hospital Mortality Using Hospital Administrative Data
resolves10.1016/j.jpain.2018.09.001
Patients’ Experience With Opioid Tapering: A Conceptual Model With Recommendations for Clinicians
resolves10.1093/pm/pnw078
Patients’ Perspectives on Tapering of Chronic Opioid Therapy: A Qualitative Study
resolves10.1080/08897077.2017.1381663
The Conundrum of Opioid Tapering in Long-Term Opioid Therapy for Chronic Pain: A Commentary
resolves10.1097/j.pain.0000000000000796
Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders
resolves10.7326/M17-0598
Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy
resolves10.1016/j.genhosppsych.2017.04.011
Suicidal ideation and suicidal self-directed violence following clinician-initiated prescription opioid discontinuation among long-term opioid users
The 4 references without a DOI — listed, not checked
no DOI — not checkedDocumentation: 2010 Rural-Urban Commuting Area (RUCA) Codes
no DOI — not checkedFDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering. US Food and Drug Administration. Published April 12, 2019. Accessed July 6, 2021. https://www.fda.gov/drugs/drug-safety-and-availability/fda-identifies-harm-reported-sudden-discontinuation-opioid-pain-medicines-and-requires-label-changes
no DOI — not checkedHHS guide for clinicians on the appropriate dosage reduction or discontinuation of long-term opioid analgesics. US Dept of Health and Human Services. Published October 2019. Accessed November 1, 2019. https://www.hhs.gov/opioids/sites/default/files/2019-10/Dosage_Reduction_Discontinuation.pdf
no DOI — not checkedChronic conditions data warehouse: condition categories. Centers for Medicare & Medicaid Services; 2019. Accessed January 28, 2019. https://www.ccwdata.org/web/guest/condition-categories
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1001/jama.2021.11013"><img src="https://citestamp.com/citestamped/10.1001/jama.2021.11013/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1001/jama.2021.11013)